Modeling Pharmacological Effects with Multi-Relation Unsupervised Graph Embedding

• URL: http://arxiv.org/abs/2004.14842v2
• Date: Fri, 15 May 2020 23:30:40 GMT
• Title: Modeling Pharmacological Effects with Multi-Relation Unsupervised Graph Embedding
• Authors: Dehua Chen, Amir Jalilifard, Adriano Veloso, Nivio Ziviani
• Abstract summary: We present a method based on a multi-relation unsupervised graph embedding model that learns latent representations for drugs and diseases. Once representations for drugs and diseases are obtained we learn the likelihood of new links (that is, new indications) between drugs and diseases. Known drug indications are used for learning a model that predicts potential indications.
• Score: 4.999039245939572
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: A pharmacological effect of a drug on cells, organs and systems refers to the specific biochemical interaction produced by a drug substance, which is called its mechanism of action. Drug repositioning (or drug repurposing) is a fundamental problem for the identification of new opportunities for the use of already approved or failed drugs. In this paper, we present a method based on a multi-relation unsupervised graph embedding model that learns latent representations for drugs and diseases so that the distance between these representations reveals repositioning opportunities. Once representations for drugs and diseases are obtained we learn the likelihood of new links (that is, new indications) between drugs and diseases. Known drug indications are used for learning a model that predicts potential indications. Compared with existing unsupervised graph embedding methods our method shows superior prediction performance in terms of area under the ROC curve, and we present examples of repositioning opportunities found on recent biomedical literature that were also predicted by our method.

Related papers

• Seeing Unseen: Discover Novel Biomedical Concepts via Geometry-Constrained Probabilistic Modeling [53.7117640028211]
  We present a geometry-constrained probabilistic modeling treatment to resolve the identified issues. We incorporate a suite of critical geometric properties to impose proper constraints on the layout of constructed embedding space. A spectral graph-theoretic method is devised to estimate the number of potential novel classes.
  arXiv  Detail & Related papers  (2024-03-02T00:56:05Z)
• Emerging Drug Interaction Prediction Enabled by Flow-based Graph Neural Network with Biomedical Network [69.16939798838159]
  We propose EmerGNN, a graph neural network (GNN) that can effectively predict interactions for emerging drugs. EmerGNN learns pairwise representations of drugs by extracting the paths between drug pairs, propagating information from one drug to the other, and incorporating the relevant biomedical concepts on the paths. Overall, EmerGNN has higher accuracy than existing approaches in predicting interactions for emerging drugs and can identify the most relevant information on the biomedical network.
  arXiv  Detail & Related papers  (2023-11-15T06:34:00Z)
• Transcriptomics-based matching of drugs to diseases with deep learning [1.590243405031747]
  We present a deep learning approach to conduct hypothesis-free, transcriptomics-based matching of drugs for diseases. Our proposed neural network architecture is trained on approved drug-disease indications, taking as input the relevant disease and drug differential gene expression profiles. We evaluate our approach against the most widely used transcriptomics-based matching baselines, CMap and the Characteristic Direction.
  arXiv  Detail & Related papers  (2023-03-21T09:32:31Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• KGML-xDTD: A Knowledge Graph-based Machine Learning Framework for Drug Treatment Prediction and Mechanism Description [11.64859287146094]
  We propose KGML-xDTD: a Knowledge Graph-based Machine Learning framework for explainably predicting Drugs Treating Diseases. We leverage knowledge-and-publication based information to extract biologically meaningful "demonstration paths" as the intermediate guidance in the Graph-based Reinforcement Learning process.
  arXiv  Detail & Related papers  (2022-11-30T17:05:22Z)
• A Deep Learning Approach to the Prediction of Drug Side-Effects on Molecular Graphs [2.4087148947930634]
  We develop a methodology to predict drug side-effects using Graph Neural Networks. We build a dataset from freely accessible and well established data sources. The results show that our method has an improved classification capability, under many parameters and metrics.
  arXiv  Detail & Related papers  (2022-11-30T10:12:41Z)
• Knowledge-Driven New Drug Recommendation [88.35607943144261]
  We develop a drug-dependent multi-phenotype few-shot learner to bridge the gap between existing and new drugs. EDGE eliminates the false-negative supervision signal using an external drug-disease knowledge base. Results show that EDGE achieves 7.3% improvement on the ROC-AUC score over the best baseline.
  arXiv  Detail & Related papers  (2022-10-11T16:07:52Z)
• Contrastive Brain Network Learning via Hierarchical Signed Graph Pooling Model [64.29487107585665]
  Graph representation learning techniques on brain functional networks can facilitate the discovery of novel biomarkers for clinical phenotypes and neurodegenerative diseases. Here, we propose an interpretable hierarchical signed graph representation learning model to extract graph-level representations from brain functional networks. In order to further improve the model performance, we also propose a new strategy to augment functional brain network data for contrastive learning.
  arXiv  Detail & Related papers  (2022-07-14T20:03:52Z)
• Deep learning for drug repurposing: methods, databases, and applications [54.08583498324774]
  Repurposing existing drugs for new therapies is an attractive solution that accelerates drug development at reduced experimental costs. In this review, we introduce guidelines on how to utilize deep learning methodologies and tools for drug repurposing.
  arXiv  Detail & Related papers  (2022-02-08T09:42:08Z)
• Graph2MDA: a multi-modal variational graph embedding model for predicting microbe-drug associations [7.149873402253933]
  Microbes have become novel targets for the development of antibacterial agents. screening of microbe-drug associations can benefit greatly drug research and development. We propose a novel method, Graph2MDA, to predict microbe-drug associations.
  arXiv  Detail & Related papers  (2021-08-14T07:33:05Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.